Back to Journals » Journal of Asthma and Allergy » Volume 11

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]

Authors Ashkenazi M, Sity S, Sarouk I, Bar Aluma BE, Dagan A, Bezalel Y, Bentur L, De Boeck K, Efrati O

Received 13 July 2018

Accepted for publication 13 July 2018

Published 13 September 2018 Volume 2018:11 Pages 245—246

DOI https://doi.org/10.2147/JAA.S180123


Ashkenazi M, Sity S, Sarouk I, et al. J Asthma Allergy. 2018;11:101–107.
 
On page 101, in the Conclusion section, the text “omlaizumb” should have been “omalizumab”.
 
Read the original article.

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]